BEAM — Beam Therapeutics Inc. stock price, charts and financials

QT31Beam Therapeutics Inc.

Beam Therapeutics Inc. (NASDAQ: BEAM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.35
+2.44+9.42%
OverviewShort InterestFilings
BEAMQT31Beam Therapeutics Inc.·NASDAQ
28.35+9.42%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 17, 2026ARSAnnual report to shareholders
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 06, 20264Statement of changes in beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 02, 20264Statement of changes in beneficial ownership
Apr 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 316
Page
▼
/ 13